These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1199991)
1. Pancreatic excretion of 5, 5-dimethyl-2, 4-oxazolidinedione in normal subjects. Noda A; Hayakawa T; Nakajima S; Suzuki T; Toda Y Am J Dig Dis; 1975 Nov; 20(11):1011-8. PubMed ID: 1199991 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic excretion of 5,5-dimethyl-2,4-oxazolidinedione in patients with chronic pancreatitis. Noda A; Hayakawa T; Aoki I; Horiguchi Y; Toda Y Am J Dig Dis; 1975 Nov; 20(11):1019-26. PubMed ID: 1199992 [TBL] [Abstract][Full Text] [Related]
3. Pancreatolithiasis and pancreatic carcinoma. Evaluation of pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione. Noda A; Kamiya N; Takayama T; Hayakawa T Arch Intern Med; 1977 Jun; 137(6):754-60. PubMed ID: 869646 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs. Noda A; Okumura I; Kato H; Ibuki E; Tamada M; Watanabe T Digestion; 1990; 46(1):19-26. PubMed ID: 2210093 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic excretion test and barrier hypothesis in progression of chronic pancreatitis. Noda A; Hayakawa T; Horiguchi Y; Naruse S; Iinuma Y Am J Gastroenterol; 1978 Jun; 69(6):673-82. PubMed ID: 707463 [TBL] [Abstract][Full Text] [Related]
6. Effect of dimethadione derived from repeated oral administration of trimethadione on pancreatic secretion in dogs. Noda A; Okumura I; Ibuki E; Hotta S; Nomoto K; Miyamoto E; Takeuchi K; Watanabe T Gastroenterol Jpn; 1990 Oct; 25(5):613-8. PubMed ID: 2227252 [TBL] [Abstract][Full Text] [Related]
7. The excretion of dimethadione in pure pancreatic juice and bile in postoperative patients. Noda A; Hayakawa T; Mizuno R; Hamano H; Murase T; Shibata T Gastroenterol Jpn; 1984 Apr; 19(2):121-6. PubMed ID: 6735069 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic study of trimethadione and dimethadione for lysis of pancreatic stones. Noda A; Yamamoto K; Nakanishi Y Gastroenterol Jpn; 1986 Apr; 21(2):167-71. PubMed ID: 3710055 [TBL] [Abstract][Full Text] [Related]
9. A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum. Kobayashi S; Tanaka E; Oguchi K; Yoshida T; Kuroiwa Y; Yasuhara H J Pharmacobiodyn; 1984 May; 7(5):329-35. PubMed ID: 6470930 [TBL] [Abstract][Full Text] [Related]
10. Effect of dimethadione administered intravenously on pancreatic secretion in dogs. Noda A; Takeuchi K; Murayama H; Ibuki E; Okumura I; Okuyama M; Okayama T; Kobayashi T J Gastroenterol Hepatol; 1994; 9(5):486-91. PubMed ID: 7827300 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis. Noda A; Hayakawa T; Kondo T; Katada N; Kameya A Dig Dis Sci; 1983 Mar; 28(3):230-5. PubMed ID: 6600678 [TBL] [Abstract][Full Text] [Related]
12. Marked secretion of pyruvate in human duodenal juice stimulated with pancreozymin or secretin. Kuroshima T; Himeno S; Okuno M; Tsuji K; Kawamoto H; Higashimoto Y; Kashimura M; Yamasaki Y; Tarui S Dig Dis Sci; 1988 Dec; 33(12):1554-9. PubMed ID: 3197585 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the marker technique for measurement of exocrine pancreatic secretion rate. Rune SJ; Worning H Scand J Gastroenterol; 1985 May; 20(4):525-9. PubMed ID: 4023620 [TBL] [Abstract][Full Text] [Related]
14. Saliva levels of trimethadione and its metabolite as an index of drug metabolizing activity in rats. Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y J Pharmacobiodyn; 1981 Dec; 4(12):922-7. PubMed ID: 7341748 [TBL] [Abstract][Full Text] [Related]
15. Physiological significance of secretin in the pancreatic bicarbonate secretion. II. Pancreatic bicarbonate response to a physiological increase in plasma secretin concentration. Schaffalitzky de Muckadell OB; Fahrenkrug J; Matzen P; Rune SJ; Worning H Scand J Gastroenterol; 1979; 14(1):85-90. PubMed ID: 424692 [TBL] [Abstract][Full Text] [Related]
16. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans. Lam WF; Masclee AA; Souverijn JH; Lamers CB Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525 [TBL] [Abstract][Full Text] [Related]
17. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease. Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S J Pharmacobiodyn; 1987 Sep; 10(9):499-502. PubMed ID: 2830397 [TBL] [Abstract][Full Text] [Related]
18. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Creutzfeldt W; Lankisch PG; Fölsch UR Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301 [TBL] [Abstract][Full Text] [Related]
19. [Pancreatic secretion in man after stimulation with cholecystokinin-pancreozymin, secretin and bile. Methods and normal ranges (author's transl)]. Otte M; Stahlheber H; Zoelch M; Forell MM; Thurmayr GR; Thurmayr R Klin Wochenschr; 1973 Sep; 51(18):915-20. PubMed ID: 4762191 [No Abstract] [Full Text] [Related]
20. Hepatic trimethadione-oxidizing capacity remains normal in patients with extrahepatic cholelithiasis. Tanaka E; Ishikawa A; Ono A; Takada A; Okamura T; Misawa S J Pharmacobiodyn; 1986 May; 9(5):506-9. PubMed ID: 3761137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]